ULTRASONOGRAPHIC EVALUATION OF TALAR CARTILAGE THICKNESS IN PATIENTS WITH DIABETIC POLYNEUROPATHY

NCT07801131 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2026-09-03

No results posted yet for this study

Summary

This study aims to evaluate talar cartilage thickness in individuals with diabetic polyneuropathy using ultrasonography and to compare the findings with those of healthy individuals. Diabetic polyneuropathy may induce biomechanical alterations in the lower extremities, which can potentially affect ankle joint structures.

Ultrasonography, a non-invasive and accessible imaging method, will be used to measure cartilage thickness. The study includes individuals with Type 2 diabetes mellitus and electromyography-confirmed diabetic polyneuropathy, as well as age-matched healthy control subjects.

The results are expected to improve understanding of musculoskeletal involvement in diabetic polyneuropathy and to support early detection of joint changes.

Conditions

  • Talar Cartilage Thickness
  • Type 2 Diabetes Mellitus
  • Type 2 Diabetes Mellitus With Diabetic Nephropathy
  • Ankle Joint
  • Diabetic Polyneuropathy
  • Ultrasonography

Sponsors & Collaborators

  • Istanbul Physical Medicine Rehabilitation Training and Research Hospital

    lead OTHER_GOV

Principal Investigators

  • Aybike Ata, Medical Doctor · Istanbul Physical Medicine and Rehabilitation Training and Research Hospital

  • Kadriye Oneş, Professor · Istanbul Physical Medicine and Rehabilitation Training and Research Hospital

  • Selim Sezikli, Specialist doctor · Istanbul Physical Medicine and Rehabilitation Training and Research Hospital

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-06-19
Primary Completion
2026-07-01
Completion
2026-07-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07801131 on ClinicalTrials.gov